Answers - Finance

As the holiday season approaches with the price of crude oil remaining relatively low juxtaposed to prices reported last year, such may be a good opportunity to purchase shares

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

of transportation companies in attempt to gain some extra profit from the unexpected support of this dependent commodity. While I am typically not in favor of purchasing any sha

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

res in industries where too much is holding on dependent factors, in the case for Air T Incorporated (AIRT), I believe there is a chance to accumulate a nice sum of capital gain

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

s come spring time.

As I mention this small cap stock, you may be wondering why I am not picking a well known company situated in the same sector, air and freight services, suc

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

as FedEx or UPS. While both of these companies are excellent in terms of what they do, more than likely, individuals are going to view these stocks more as long term investment

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

s rather than a short speculating session. Such can be a positive indication as what does interest me of Air T in relation to the other two giant firms is their relative P/E rat

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

io. While FedEx and UPS have posted pretty solid numbers in the 10-20 range, what I notice about Air T is its ratio currently of 9.41. For a company in such an industry, such a

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

rice is relatively low to its competitors and might signal a strong boost in terms of its share price in the near future. Come early 2007 when Air T announces its earning result

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s coupled with a possibly strong holiday sending session, you should see the share price of Air T, which already is near its 52 week low, prop up to amazing levels. While the sa

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

me logic can be said about FedEx or UPS as they all utilize the same procedures to obtain profit, because Air T is near such a low but still remains to keep a strong P/E ratio,

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

believe this company has reached its support level and has no other option but go up in terms of share price.

When looking at more concrete information, Air T has done pretty

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

solid when it has come to fundamentals. It’s true that operating income has not increased from year to year at a rate favorable to many investors, but nevertheless, revenue grow

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

th still has been strong which supports the strong earnings, and liabilities have been decreasing at a rate faster than the more valuable total assets. Trend wise, Air T has rem

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ained relatively flat for the previous few years. Nonetheless, my suggestion for purchasing shares of this stock remains as a short term investment (until a good few day rally),

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

as I do not believe this stock will remain as productive when oil prices return to their respective highs. In the short term however, because this stock is a small cap equity wi

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

th low volume and because this stock has a history of being volatile in many situations, I would encourage purchasing shares now to take advantage of the low commodity prices an

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

d the holiday shopping season. Both of these factors will have tremendous benefits to not only the fundamentals of this company but to its relative share price value as well.

T

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

erefore, while a better long term investment may rest with companies such as FedEx or UPS due to their relative stronghold and stability, if you, as an investor, are looking for

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

a short term purchase with a high risk but higher reward, look no further than purchasing Air T. With a strong P/E ratio along with fairly positive economic and seasonal indica

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tors, at such a price, regardless if the company will buy back its stock or not, this stock will be enticing for any investor to stimulate his or her capital gains to the upside

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/117050/answers-A-Short-Term-Buy-Air-T-Incorporated.html">A Short Term Buy: Air T Incorporated</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/117050/answers-A-Short-Term-Buy-Air-T-Incorporated.html]A Short Term Buy: Air T Incorporated[/url]

Don't let the hustle and bustle of the busy holiday season keep you from preparing to make next year your best year yet. Here are some thoughts and tips for your year-end To-Do list.

Prospecting for future customers can be fun if you approach it the right way. It is not a wild goose chase; it is a wild goose HUNT. Cold prospecting requires you to start from nothing and end up with the name and contact information of the person who can say “yes” to you. If you are in a situation where you have to use cold prospecting as a way to generate sales, you should go in fully prepared.

Tags

Links

Answers - A Short Term Buy: Air T Incorporated

Related Articles: